304 related articles for article (PubMed ID: 8387835)
1. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China.
van Gorp J; Weiping L; Jacobse K; Liu YH; Li FY; De Weger RA; Li G
J Pathol; 1994 Jun; 173(2):81-7. PubMed ID: 7522272
[TBL] [Abstract][Full Text] [Related]
4. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
[TBL] [Abstract][Full Text] [Related]
5. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
6. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of Epstein-Barr virus-associated nasal T/NK cell lymphomas in southern Japan.
Seki D; Ueno K; Kurono Y; Eizuru Y
Auris Nasus Larynx; 2001 Jan; 28(1):61-70. PubMed ID: 11137365
[TBL] [Abstract][Full Text] [Related]
8. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.
Emile JF; Boulland ML; Haioun C; Kanavaros P; Petrella T; Delfau-Larue MH; Bensussan A; Farcet JP; Gaulard P
Blood; 1996 Feb; 87(4):1466-73. PubMed ID: 8608237
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas.
Ohno T; Yamaguchi M; Oka K; Miwa H; Kita K; Shirakawa S
Leukemia; 1995 Jan; 9(1):44-52. PubMed ID: 7845028
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
11. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of lethal midline granuloma thought to be of natural killer cell origin].
Tamura S; Yamanaka N; Saito T; Takano I; Hotomi M; Yokoyama M
Nihon Jibiinkoka Gakkai Kaiho; 1996 Jan; 99(1):46-53. PubMed ID: 8822254
[TBL] [Abstract][Full Text] [Related]
13. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.
Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT
Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.
Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K
Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131
[TBL] [Abstract][Full Text] [Related]
15. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
16. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
17. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities.
Kuo TT; Shih LY; Tsang NM
Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863
[TBL] [Abstract][Full Text] [Related]
18. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin.
Chiang AK; Srivastava G; Lau PW; Ho FC
Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315
[TBL] [Abstract][Full Text] [Related]
19. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
20. Detection of epstein-barr virus in nasal T-cell lymphoma.
Makoshi T; Takahashi H; Kameya T; Yao K; Sato Y; Nakayama M; Tsuchiya B; Okamoto M
Acta Otolaryngol Suppl; 2002; (547):46-9. PubMed ID: 12212593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
